ResMed Director Files Intent to Sell $122K in Stock
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
ResMed Director Files Intent to Sell $122K in Stock
Company: RESMED INC (RMD) Form: 144 | Filed: 2025-11-12 Significance: Low
Insider: De Witte Jan Title: Director | Relationship: Director
Transaction: • Type: Proposed Sale • Shares: 487 • Value: $121,871.75 • Price/Share: ~$250.25
Key Insight: This is a very small, routine sale representing a negligible fraction (0.0003%) of the company's market cap. The sale was filed under a pre-arranged trading plan adopted in Feb 2025, indicating it is not based on new non-public information.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: RESMED INC (RMD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director at ResMed has filed a notice of proposed sale for a small lot of shares, valued at approximately $122K, under a pre-established 10b5-1 trading plan.
- Market Impact: The transaction is immaterial and expected to have no impact on the stock price due to its minuscule size relative to the company's market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | RESMED INC |
| Ticker Symbol | RMD |
| CIK | 0000943819 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | De Witte Jan |
| CIK | 0001776929 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-11 (Approximate Sale Date) |
| Transaction Type | Proposed Sale |
| Security Type | Common Stock |
| Shares Involved | 487 |
| Price Per Share | ~$250.25 (Calculated) |
| Total Value | $121,871.75 |
| Shares Owned After | Not Available |
| Ownership Type | Not Specified |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $121,871.75 |
| % of Market Cap | 0.0003% |
| Shares Transacted | 487 |
| % of Shares Outstanding | 0.0003% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $36.51 billion, this $122K transaction is financially insignificant and considered routine.
- Transaction Significance: The sale represents a negligible fraction of both the market capitalization and shares outstanding, falling far below the thresholds for moderate or high significance. It is likely for personal liquidity or tax planning purposes.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction size is too small to have any market-moving effect. It is a routine filing by an insider.
Volume & Sentiment
- Expected Volume Impact: None. The number of shares is trivial compared to daily trading volume.
- Sentiment Indicator: Neutral. This filing does not signal any change in the insider's outlook on the company.
Additional Context
Special Circumstances
- The filing notes a plan adoption date of February 3, 2025, indicating this proposed sale is pursuant to a Rule 10b5-1 trading plan. Such plans are established in advance to automate transactions and are not based on immediate market events.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.